The molecular mechanism behind this effect involved the increased expression of CD44, a cancer stem cell marker in numerous human solid tumors [116], and subsequent upregulation of asialoglycoprotein receptor 2 (ASGRA2), which acts as an oncogene in gastric cancer [115]. The gene discussed is CD44; the disease is gastric cancer.